Benchmark Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Benchmark Financial's LLY Position: Q3 2026 in Review
Benchmark Financial held its Eli Lilly (LLY) position steady in Q3 2026 at 276 shares worth $319K. The position accounts for 0.25% of the portfolio, ranked #49.
Benchmark Financial first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $331K in Q2 2026. 2,910 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Benchmark Financial held 276 shares of Eli Lilly worth $319K as of Q3 2026.
- Benchmark Financial left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.25% of Benchmark Financial's portfolio in Q3 2026, its #49 holding.
- Benchmark Financial first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Benchmark Financial's Eli Lilly position peaked at $331K in Q2 2026.
- 2,910 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Benchmark Financial's 13F filing for Q3 2026, filed 16 Oct 2026.